Multifunctional benzoxazines and composite materials incorporating the same

Patent metadata

Field	Value
Publication number	US-9822219-B2
Application number	US-201414562799-A
Country	US
Kind code	B2
Filing date	Dec 8, 2014
Priority date	Dec 20, 2013
Publication date	Nov 21, 2017
Grant date	Nov 21, 2017

Abstract

A curable resin composition containing a blend of multifunctional benzoxazines, and composite materials derived therefrom. The benzoxazine blend contains the combination of (A) a difunctional benzoxazine component and (B) a multifunctional benzoxazine component with functionality of greater than 2. Cured matrix resins and cured composite materials containing such benzoxazine blend exhibit a significant retardation in the rate of organic solvent uptake as compared to the same cured matrix resins and composite materials without component (B).

First claim

What is claimed is:

1. A curable resin composition comprising more than 80% by weight of a benzoxazine blend, wherein the benzoxazine blend comprises: (A) a difunctional benzoxazine component; and (B) a multifunctional benzoxazine component with an average functionality of greater than 2,
wherein component (B) comprises a tri-functional benzoxazine compound represented by the following structure I:

where R 1 , R 2 and R 3 are independently selected from alkyl, cycloalkyl, and aryl, wherein the cycloalkyl and aryl groups are optionally substituted, and where substituted, one or more substituent groups may be present on each cycloalkyl and aryl group; and R 4 is selected from hydrogen, halogen, alkyl and alkenyl,
wherein component (B) is a reaction product of trihydric phenol, aromatic amine and formaldehyde, and
wherein the multifunctional benzoxazine component (B) is present in an amount up to 30% by weight based on the total weight of the benzoxazine blend in the composition.

2. The curable resin composition of claim 1 , wherein upon curing of the resin composition to form a cured resin, the cured resin exhibits a slow rate of organic solvent uptake that is 5 times slower relative to the same cured resin without component (B).

3. A curable resin composition comprising more than 80% by weight of a benzoxazine blend, wherein the benzoxazine blend comprises: (A) a difunctional benzoxazine component; and (B) a multifunctional benzoxazine component with an average functionality of greater than 2,
wherein component (B) comprises a tri-functional benzoxazine compound represented by the following structure II:

where R 1 , R 2 and R 3 are alkyl, and
wherein the multifunctional benzoxazine component (B) is present in an amount up to 30% by weight based on the total weight of the benzoxazine blend in the composition.

4. The curable resin composition of claim 3 , wherein
R 1 , R 2 and R 3 of Structure II are independently selected from C 1-8 alkyl.

5. The curable resin composition of claim 4 , wherein component (B) comprises a tri-functional benzoxazine represented by the following structure III:

6. The curable resin composition of claim 5 , wherein component (B) is a reaction product of 1,1,1-Tris (4-hydroxyphenyl)ethane, p-toluidine and p-formaldehyde.

7. The curable resin composition of claim 3 , wherein the weight ratio of multifunctional benzoxazine component (B) to difunctional benzoxazine component (A) is within the range of 1:99 to 30:70.

8. The curable resin composition of claim 3 , wherein component (B) is a reaction product of trihydric phenol, aromatic amine and formaldehyde.

9. The curable resin composition according to claim 3 , wherein the difunctional benzoxazine is represented by the following structure (IV):

where:
Z 1 is selected from a direct bond, —C(R 3 )(R 4 )—, —C(R 3 )(aryl)-, —C(O)—, —S—, —O—, —S(O)—, —S(O) 2 —, a divalent heterocycle and —[C(R 3 )(R 4 )] x -arylene-[C(R 5 )(R 6 )] y —, or the two benzyl rings of the benzoxazine moieties may be fused; and
R 1 and R 2 are independently selected from alkyl, cycloalkyl, and aryl, wherein the cycloalkyl and aryl groups are optionally substituted by a substituent selected from: C 1-8 alkyl, halogen and amine groups, and where substituted, one or more substituent groups may be present on each cycloalkyl and aryl group;
R 3 , R 4 , R 5 and R 6 are independently selected from H, C 1-8 alkyl, and halogenated alkyl; and
x and y are independently 0 or 1.

10. The curable resin composition according to claim 3 , wherein the di-functional benzoxazine is represented by the following structure V:

where:
Z 1 is selected from a direct bond, —C(R 3 )(R 4 )—, —C(R 3 )(aryl)-, —C(O)—, —S—, —O—, —S(O)—, —S(O) 2 —, a divalent heterocycle and —[C(R 3 )(R 4 )] x -arylene-[C(R 5 )(R 6 )] y —, or the two benzyl rings may be fused; and
R 1 and R 2 are independently selected from hydrogen, alkyl, cycloalkyl and aryl, wherein the cycloalkyl and aryl groups are optionally substituted by a substituent selected from: C 1-8 alkyl, halogen and amine groups, and where substituted, one or more substituent groups may be present on each cycloalkyl and aryl group;
R 3 , R 4 , R 5 and R 6 are independently selected from H, C 1-8 alkyl, and halogenated alkyl; and
x and y are independently 0 or 1.

11. The curable resin composition of claim 3 , wherein the curable composition is void of or contains less than 5% by weight, based on the total weight of the composition, of any thermosettable resin selected from epoxy, cyanate ester, bismaleimide, and phenol-formaldehyde.

12. A composite material comprising reinforcement fibers impregnated or infused with the curable composition according to claim 3 .

13. The composite material of claim 12 , wherein the reinforcement fibers are selected from carbon fibers, glass fibers, and aramid fibers.

14. The composite material of claim 12 , wherein the reinforcement fibers are in the form of unidirectional fibers, a fabric, or a preform comprising multiple layers of fibers or fabric plies.

15. A curable resin composition comprising more than 80% by weight of a benzoxazine blend, wherein the benzoxazine blend comprises: (A) a difunctional benzoxazine component; and (B) a multifunctional benzoxazine component with an average functionality of greater than 2 and up to 3,
wherein component (B) is a reaction product of trihydric phenol, aromatic amine and formaldehyde, and the trihydric phenol is represented by the following structure:

and
component (B) is present in an amount up to 30% by weight based on the total weight of the benzoxazine blend in the composition.

16. The curable resin composition of claim 15 , wherein component (B) is a reaction product of 1,1,1-Tris (4-hydroxyphenyl)ethane, p-toluidine and p-formaldehyde.

17. The curable resin composition of claim 15 , wherein the weight ratio of component (B) to component (A) is within the range of 1:99 to 30:70.

18. The curable resin composition according to claim 15 , wherein the curable composition is void of or contains less than 5% by weight, based on the total weight of the composition, of any thermosettable resin selected from epoxy, cyanate ester, bismaleimide, and phenol-formaldehyde.

19. A cured composite part produced from a method comprising: (i) impregnating or infusing reinforcement fibers with the curable composition according to claim 1 ; and (ii) curing the impregnated or infused fibers.

Assignees

• Cytec Ind Inc

Inventors

• Ward Steven Richard
• Cross Paul Mark

Classifications

• D06M15/61

  Polyamines {polyimines} · CPC title

• C07D265/14

  condensed with one six-membered ring · CPC title

• C08K5/357 Primary

  Six-membered rings · CPC title

• C08K5/375

  containing six-membered aromatic rings {(C08K5/3725 takes precedence)} · CPC title

• C07D265/16

  with only hydrogen or carbon atoms directly attached in positions 2 and 4 · CPC title